These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20176395)

  • 1. Alternatively spliced isoforms of tissue factor pathway inhibitor.
    Maroney SA; Ellery PE; Mast AE
    Thromb Res; 2010 Apr; 125 Suppl 1():S52-6. PubMed ID: 20176395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-evaluation of mouse tissue factor pathway inhibitor and comparison of mouse and human tissue factor pathway inhibitor physiology.
    Girard TJ; Grunz K; Lasky NM; Malone JP; Broze GJ
    J Thromb Haemost; 2018 Nov; 16(11):2246-2257. PubMed ID: 30194803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal expression of alternatively spliced forms of tissue factor pathway inhibitor in mice.
    Maroney SA; Ferrel JP; Pan S; White TA; Simari RD; McVey JH; Mast AE
    J Thromb Haemost; 2009 Jul; 7(7):1106-13. PubMed ID: 19422457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TFPIα and TFPIβ are expressed at the surface of breast cancer cells and inhibit TF-FVIIa activity.
    Stavik B; Tinholt M; Sletten M; Skretting G; Sandset PM; Iversen N
    J Hematol Oncol; 2013 Jan; 6():5. PubMed ID: 23320987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the inhibitory activities of human tissue factor pathway inhibitor (TFPI)α and TFPIβ.
    Maroney SA; Ellery PE; Wood JP; Ferrel JP; Martinez ND; Mast AE
    J Thromb Haemost; 2013 May; 11(5):911-8. PubMed ID: 23480518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue factor pathway inhibitor-gamma is an active alternatively spliced form of tissue factor pathway inhibitor present in mice but not in humans.
    Maroney SA; Ferrel JP; Collins ML; Mast AE
    J Thromb Haemost; 2008 Aug; 6(8):1344-51. PubMed ID: 18503630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biology of tissue factor pathway inhibitor.
    Wood JP; Ellery PE; Maroney SA; Mast AE
    Blood; 2014 May; 123(19):2934-43. PubMed ID: 24620349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular expression and biological activities of alternatively spliced forms of tissue factor pathway inhibitor.
    Maroney SA; Hansen KG; Mast AE
    Curr Opin Hematol; 2013 Sep; 20(5):403-9. PubMed ID: 23839295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation.
    Wood JP; Bunce MW; Maroney SA; Tracy PB; Camire RM; Mast AE
    Proc Natl Acad Sci U S A; 2013 Oct; 110(44):17838-43. PubMed ID: 24127605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-α but not for cell surface-associated tissue factor pathway inhibitor.
    Wood JP; Ellery PE; Maroney SA; Mast AE
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):169-76. PubMed ID: 24233490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of tissue factor pathway inhibitor isoform beta or gamma, but not alpha, improves clotting in hemophilic mice.
    Eldem I; Antunes-Heck L; Subramanian R; Lasky NM; Ashworth K; Di Paola J; Girard TJ
    J Thromb Haemost; 2024 Oct; 22(10):2681-2691. PubMed ID: 38925489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue factor pathway inhibitor: structure-function.
    Broze GJ; Girard TJ
    Front Biosci (Landmark Ed); 2012 Jan; 17(1):262-80. PubMed ID: 22201743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cell-surface TFPIalpha and beta.
    Piro O; Broze GJ
    J Thromb Haemost; 2005 Dec; 3(12):2677-83. PubMed ID: 16246254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translation of human tissue factor pathway inhibitor-β mRNA is controlled by alternative splicing within the 5' untranslated region.
    Ellery PE; Maroney SA; Martinez ND; Wickens MP; Mast AE
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):187-95. PubMed ID: 24233486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syndecan-3 and TFPI colocalize on the surface of endothelial-, smooth muscle-, and cancer cells.
    Tinholt M; Stavik B; Louch W; Carlson CR; Sletten M; Ruf W; Skretting G; Sandset PM; Iversen N
    PLoS One; 2015; 10(1):e0117404. PubMed ID: 25617766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue Factor Pathway Inhibitor: Multiple Anticoagulant Activities for a Single Protein.
    Mast AE
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):9-14. PubMed ID: 26603155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into the biology of tissue factor pathway inhibitor.
    Maroney SA; Mast AE
    J Thromb Haemost; 2015 Jun; 13 Suppl 1(0 1):S200-7. PubMed ID: 26149025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of coagulation by tissue factor pathway inhibitor: Implications for hemophilia therapy.
    Mast AE; Ruf W
    J Thromb Haemost; 2022 Jun; 20(6):1290-1300. PubMed ID: 35279938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TFPIβ is the GPI-anchored TFPI isoform on human endothelial cells and placental microsomes.
    Girard TJ; Tuley E; Broze GJ
    Blood; 2012 Feb; 119(5):1256-62. PubMed ID: 22144186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF.
    Tinholt M; Vollan HK; Sahlberg KK; Jernström S; Kaveh F; Lingjærde OC; Kåresen R; Sauer T; Kristensen V; Børresen-Dale AL; Sandset PM; Iversen N
    Breast Cancer Res; 2015 Mar; 17(1):44. PubMed ID: 25882602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.